Skip to main content
Premium Trial:

Request an Annual Quote

Battelle Forms Datamining, Visualization Software Co.

Premium

C

OLUMBUS, Ohio--Battelle has formed a new datamining and visualization company called OmniViz, focused on the life sciences and chemical industries in addition to academic and government institutions. OmniViz will use Battelle’s OmniViz Pro software, which allows users to analyze and integrate text, numerical, categorical, and genomic sequence data. "We recently initiated a collaboration with the Robert Wood Johnson Pharmaceutical Research Institute and Janssen Research Foundation to develop future generations of OmniViz Pro and other datamining and visualization software," said Ben Maiden, senior vice-president and general manager for Battelle’s Chemical Products market sector. Battelle will be releasing OmniViz Pro version 1.0 on a selected basis in April and to the broader marketplace shortly thereafter.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.